NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblastsJosep Amengual, Javier Vaquero, Mariana Yáñez-Bartolomé et al.|Signal Transduction and Targeted Therapy|2025Cited by 8
Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific VulnerabilitiesAlexander Scheiter, Kirsten Utpatel|Journal of Personalized Medicine|2022Cited by 7
RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venuesAlexander Scheiter, Kirsten Utpatel|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1